In the vehicle + TFI group, IL-13 immunoreactivity in the pyramidal cells was significantly reduced at 2 days (83.1% versus the vehicle + sham group) and more decreased (17.6% versus the vehicle + sham group) at 5 days post-ischemia (Figure 5B(b,c,)D). This evidence concerns the gene IL13 and ischemia.